hSHIP负调PI3K/AKt信号通路对HeLa细胞增殖与凋亡的影响
摘要
背景:hSHIP(Human SH2 domain-containing inositol 5′-phosphatase,人含SH2结构域肌醇磷酸酯酶)属于肌醇5'磷酸酯酶家族,主要在造血细胞中表达。研究显示,SHIP能通过PI3K/Akt信号通路对造血细胞增殖、存活及终端细胞活化起到负调节作用。本文主要探究hSHIP是否诱导PI3K/Akt信号通路异常活化的非造血肿瘤细胞(HeLa)的细胞周期发生阻滞作用及凋亡。
方法:以人外周血单个核细胞总RNA为模板,RT-PCR扩增hSHIP基因的全长cDNA编码区序列,将其插入pcDNA3.1-GFP中,构建pcDNA3.1-GFP-hSHIP真核表达载体;用脂质体法转染HeLa细胞,经G418筛选,单克隆化细胞培养及采用荧光显微镜观察和Western blotting进一步鉴定以获得稳定表达目的基因的HeLa细胞株;流式细胞术检测细胞周期;caspase-3活性检测实验及Hoechst33258/PI双染色法分析细胞凋亡;MTT法及裸鼠体内成瘤实验检测细胞增殖与存活;半定量RT-PCR及Western blotting检测Akt的表达情况及ELISA法检测Akt磷酸化水平。
结果:成功构建了pcDNA3.1-GFP-hSHIP真核表达载体,并成功建立了稳定转染HeLa细胞株(HeLa/hSHIP-GFP,HeLa/GFP)。与对照组(HeLa/GFP)相比,细胞处于S期的比例从27.3±4.50%上升到47.2±7.78%(P＜0.05),G2/M期从14.5±1.91%减少到2.6±0.71%(P＜0.05),显示hSHIP将HeLa细胞的细胞周期阻滞于S期;Hoechst33258/PI和caspase-3活性检测显示了hSHIP对HeLa细胞起促凋亡作用;MTT法显示96小时后hSHIP对HeLa细胞的生长抑制率高达80.91%(P＜0.05),裸鼠体内成瘤实验显示HeLa/hSHIP-GFP细胞生长显著减缓,瘤体重量比为255.0±50mg vs 117.5±35mg(P＜0.05),实验组的抑瘤率为53.92%(P＜0.05);进一步检测表明,总Akt蛋白及Akt1/2 mRNA的表达及Akt磷酸化水平明显下调。
结论:本文研究提示,hSHIP能显著抑制HeLa细胞的增殖及存活,诱导HeLa细胞阻滞于S期及凋亡,其机制可能与Akt表达及磷酸化水平下调有关。这些研究工作为进一步探讨hSHIP的抗肿瘤机制及为其他PI3K/Akt信号通路异常活化的非造血肿瘤的抑癌作用的研究奠定基础。
Background:Human SH2-containing inositol-5-phosphatase(hSHIP)belongs to inositol phosphatase family and restricts to hematopoietic cells.The studies showed that hSHIP acts as a negative regulator of proliferation,survival and end cell activation in hematopoietic cells.To explore whether hSHIP induces apoptosis and cell cycle arrest in nonhaemopoietic tumors with abnormal activation of PI3K/Akt.
Methods:The full-length SHIP cDNA fragment was amplified by RT-PCR from the human peripheral blood mononuclear cells and subcloned into pcDNA3.1-GFP vector to construct pcDNA3.1-hSHIP-GFP full-length vector.pcDNA3.1-hSHIP-GFP and pcDNA3.1-GFP(control)were transfected into HeLa cells by Lipofectamine~(TM)2000,The stable transfected HeLa cell lines were then established by screening culture with G418,and the expression of hSHIP-GFP and GFP were identified by Flurescent microscope and Western blotting.Cell cycle was examined by Flow cytometry.Apoptosis was detected by Hoechst33258/ PI and caspase3 activity assay.Cell growth was determined by MTT assay and tumorigenicity in nude mice.The levels of Akt expression were measured by semi-quantitative RT-PCR and Western blotting,and phosphorylation of Akt(Ser473)was abserved by ELISA.
Results:The eukaryotic expression vector pcDNA3.1-hSHIP-GFP were contracted successfully,and stable transfected HeLa cell lines were established.Flow cytometry analysis showed that expression of hSHIP remarkably increased the proportion of HeLa cells in S-phase(from 27.3±4.50%to 47.2±7.78%,P＜0.05)and decreased the proportion of cells in G_2/M phase(from 14.5±1.91%to 2.6±0.71%, P＜0.05),these data showed that hSHIP significantly induced S-phase arrest of HeLa cells.hSHIP-induced apoptosis reflected by Hoechst33258/PI and caspase-3 activity assay.The cell growth was reduced by 80.19%(P＜0.05)at 96h,and the tumorigenicity in nude mice was reduced evidently(255.0±50mg vs 117.5±35mg, P＜0.05),the ratio of inhibition of tumor was 53.92%(P＜0.05),Further tests showed that hSHIP leads to down-regulate expression of Akt and phosphorylation of Akt.
Conclusion:In this study,hSHIP can significantly inhibit proliferation and survival of HeLa cells,and induce S arrest and apoptosis.The possible mechanism is related to downregulation of the expression and phosphorylation of Akt.These results would contribute to the further study of its anti-tumor biological functions and the suppression of other nonhaemopoietic tumors with abnormal activation of PI3K/Akt by hSHIP.
方法:以人外周血单个核细胞总RNA为模板,RT-PCR扩增hSHIP基因的全长cDNA编码区序列,将其插入pcDNA3.1-GFP中,构建pcDNA3.1-GFP-hSHIP真核表达载体;用脂质体法转染HeLa细胞,经G418筛选,单克隆化细胞培养及采用荧光显微镜观察和Western blotting进一步鉴定以获得稳定表达目的基因的HeLa细胞株;流式细胞术检测细胞周期;caspase-3活性检测实验及Hoechst33258/PI双染色法分析细胞凋亡;MTT法及裸鼠体内成瘤实验检测细胞增殖与存活;半定量RT-PCR及Western blotting检测Akt的表达情况及ELISA法检测Akt磷酸化水平。
结果:成功构建了pcDNA3.1-GFP-hSHIP真核表达载体,并成功建立了稳定转染HeLa细胞株(HeLa/hSHIP-GFP,HeLa/GFP)。与对照组(HeLa/GFP)相比,细胞处于S期的比例从27.3±4.50%上升到47.2±7.78%(P＜0.05),G2/M期从14.5±1.91%减少到2.6±0.71%(P＜0.05),显示hSHIP将HeLa细胞的细胞周期阻滞于S期;Hoechst33258/PI和caspase-3活性检测显示了hSHIP对HeLa细胞起促凋亡作用;MTT法显示96小时后hSHIP对HeLa细胞的生长抑制率高达80.91%(P＜0.05),裸鼠体内成瘤实验显示HeLa/hSHIP-GFP细胞生长显著减缓,瘤体重量比为255.0±50mg vs 117.5±35mg(P＜0.05),实验组的抑瘤率为53.92%(P＜0.05);进一步检测表明,总Akt蛋白及Akt1/2 mRNA的表达及Akt磷酸化水平明显下调。
结论:本文研究提示,hSHIP能显著抑制HeLa细胞的增殖及存活,诱导HeLa细胞阻滞于S期及凋亡,其机制可能与Akt表达及磷酸化水平下调有关。这些研究工作为进一步探讨hSHIP的抗肿瘤机制及为其他PI3K/Akt信号通路异常活化的非造血肿瘤的抑癌作用的研究奠定基础。
Background:Human SH2-containing inositol-5-phosphatase(hSHIP)belongs to inositol phosphatase family and restricts to hematopoietic cells.The studies showed that hSHIP acts as a negative regulator of proliferation,survival and end cell activation in hematopoietic cells.To explore whether hSHIP induces apoptosis and cell cycle arrest in nonhaemopoietic tumors with abnormal activation of PI3K/Akt.
Methods:The full-length SHIP cDNA fragment was amplified by RT-PCR from the human peripheral blood mononuclear cells and subcloned into pcDNA3.1-GFP vector to construct pcDNA3.1-hSHIP-GFP full-length vector.pcDNA3.1-hSHIP-GFP and pcDNA3.1-GFP(control)were transfected into HeLa cells by Lipofectamine~(TM)2000,The stable transfected HeLa cell lines were then established by screening culture with G418,and the expression of hSHIP-GFP and GFP were identified by Flurescent microscope and Western blotting.Cell cycle was examined by Flow cytometry.Apoptosis was detected by Hoechst33258/ PI and caspase3 activity assay.Cell growth was determined by MTT assay and tumorigenicity in nude mice.The levels of Akt expression were measured by semi-quantitative RT-PCR and Western blotting,and phosphorylation of Akt(Ser473)was abserved by ELISA.
Results:The eukaryotic expression vector pcDNA3.1-hSHIP-GFP were contracted successfully,and stable transfected HeLa cell lines were established.Flow cytometry analysis showed that expression of hSHIP remarkably increased the proportion of HeLa cells in S-phase(from 27.3±4.50%to 47.2±7.78%,P＜0.05)and decreased the proportion of cells in G_2/M phase(from 14.5±1.91%to 2.6±0.71%, P＜0.05),these data showed that hSHIP significantly induced S-phase arrest of HeLa cells.hSHIP-induced apoptosis reflected by Hoechst33258/PI and caspase-3 activity assay.The cell growth was reduced by 80.19%(P＜0.05)at 96h,and the tumorigenicity in nude mice was reduced evidently(255.0±50mg vs 117.5±35mg, P＜0.05),the ratio of inhibition of tumor was 53.92%(P＜0.05),Further tests showed that hSHIP leads to down-regulate expression of Akt and phosphorylation of Akt.
Conclusion:In this study,hSHIP can significantly inhibit proliferation and survival of HeLa cells,and induce S arrest and apoptosis.The possible mechanism is related to downregulation of the expression and phosphorylation of Akt.These results would contribute to the further study of its anti-tumor biological functions and the suppression of other nonhaemopoietic tumors with abnormal activation of PI3K/Akt by hSHIP.
引文
1.Lioubin,M.N.,et al.,p150Ship,a signal transduction molecule with inositol polyphosphate-5-phosphatase activity.Genes Dev,1996.10(9):p.1084-95.
2.Tu,Z.,et al.,Embryonic and hematopoietic stem cells express a novel SH2-containing inositol 5'-phosphatase isoform that partners with the Grb2 adapter protein.Blood,2001.98(7):p.2028-38.
3.Backers,K.,et al.,The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases.Adv Enzyme Regul,2003.43:p.15-28.
4.Ware,M.D.,et al.,Cloning and characterization of human SHIP,the 145-kD inositol 5-phosphatase that associates with SHC after cytokine stimulation.Blood,1996.88(8):p.2833-40.
5.Sly,L.M.,et al.,SHIP,SHIP2,and PTEN activities are regulated in vivo by modulation of their protein levels:SHIP is up-regulated in macrophages and mast cells by lipopolysaccharide.Exp Hematol,2003.31(12):p.1170-81.
6.Velazquez,L.,et al.,The shc adaptor protein forms interdependent phosphotyrosine-mediated protein complexes in mast cells stimulated with interleukin 3.Blood,2000.96(1):p.132-8.
7.Bone,H.and M.J.Welham,Shc associates with the IL-3 receptor beta subunit,SHIP and Gab2 following IL-3 stimulation.Contribution of Shc PTB and SH2 domains.Cell Signal,2000.12(3):p.183-94.
8.Lee,J.O.,et al.,Crystal structure of the PTEN tumor suppressor:implications for its phosphoinositide phosphatase activity and membrane association.Cell,1999.99(3):p.323-34.
9.Giri,D.and M.Ittmann,Inactivation of the PTEN tumor suppressor gene is associated with increased angiogenesis in clinically localized prostate carcinoma.Hum Pathol,1999.30(4):p.419-24.
10.Damen,J.E.,et al.,The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase.Proc Natl Acad Sci USA,1996.93(4):p.1689-93.
11.Rauh,M.J.,et al.,Role of Src homology 2-containing-inositol 5'-phosphatase(SHIP) in mast cells and macrophages.Biochem Soc Trans,2003.31(Pt 1):p.286-91.
12.Liu,Q.,et al.,The SH2-containing inositol polyphosphate 5-phosphatase,ship,is expressed during hematopoiesis and spermatogenesis.Blood,1998.91(8):p.2753-9.
13.Brauweiler,A.,et al.,Partially distinct molecular mechanisms mediate inhibitory FcgammaRIIB signaling in resting and activated B cells.J Immunol,2001.167(1):p.204-11.
14.Maresco,D.L.,et al.,The SH2-containing 5'-inositol phosphatase(SHIP) is tyrosine phosphorylated after Fc gamma receptor clustering in monocytes.J Immunol,1999.162(11):p.6458-65.
15.Cox,D.,et al.,A regulatory role for Src homology 2 domain-containing inositol 5'-phosphatase(SHIP) in phagocytosis mediated by Fc gamma receptors and complement receptor 3(alpha(M)beta(2);CD11b/CD18).J Exp Med,2001.193(1):p.61-71.
16.Giuriato,S.,et al.,Tyrosine phosphorylation and relocation of SHIP are integrin-mediated in thrombin-stimulated human blood platelets.J Biol Chem,1997.272(43):p.26857-63.
17.Maxwell,M.J.,et al.,SHIP1 and Lyn Kinase Negatively Regulate Integrin alpha Ⅱb beta 3 signaling in platelets.J Biol Chem,2004.279(31):p.32196-204.
18.Lucas,D.M.and L.R.Rohrschneider,A novel spliced form of SH2-containing inositol phosphatase is expressed during myeloid development.Blood,1999.93(6):p.1922-33.
19.Wolf,I.,et al.,Cloning of the genomic locus of mouse SH2 containing inositol 5-phosphatase (SHIP) and a novel 110-kDa splice isoform,SHIPdelta.Genomics,2000.69(1):p.104-12.
20.Tu,Z.,et al.,Embryonic and hematopoietic stem cells express a novel SH2-containing inositol 5'-phosphatase isoform that partners with the Grb2 adapter protein.Blood,2001.98(7):p.2028-38.
21.Kalesnikoff,J.,et al.,The role of SHIP in cytokine-induced signaling.Rev Physiol Biochem Pharmacol,2003.149:p.87-103.
22.Pesesse,X.,et al.,Identification of a second SH2-domain-containing protein closely related to the phosphatidylinositol polyphosphate 5-phosphatase SHIP.Biochem Biophys Res Commun,1997.239(3):p.697-700.
23.Muraille,E.,et al.,Distribution of the src-homology-2-domain-containing inositol 5-phosphatase SHIP-2 in both non-haemopoietic and haemopoietic cells and possible involvement of SHIP-2 in negative signalling of B-cells.Biochem J,1999.342 Pt 3:p.697-705.
24.Wisniewski,D.,et al.,A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase(SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene(SHC) in chronic myelogenous leukemia progenitor cells.Blood,1999.93(8):p.2707-20.
25.Bruyns,C.,et al.,The two SH2-domain-containing inositol 5-phosphatases SHIP1 and SHIP2are coexpressed in human T lymphocytes.Biol Chem,1999.380(7-8):p.969-74.
26.Pesesse,X.,et al.,The SH2 domain containing inositol 5-phosphatase SHIP2 displays phosphatidylinositol 3,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate 5-phosphatase activity.FEBS Lett,1998.437(3):p.301-3.
27.Dyson,J.M.,et al.,The SH2-containing inositol polyphosphate 5-phosphatase,SHIP-2,binds filamin and regulates submembraneous actin.J Cell Biol,2001.155(6):p.1065-79.
28.Krystal,G.,Lipid phosphatases in the immune system.Semin Immunol,2000.12(4):p.397-403.
29.Ishihara,H.,et al.,Molecular cloning of rat SH2-containing inositol phosphatase 2(SHIP2)and its role in the regulation of insulin signaling.Biochem Biophys Res Commun,1999.260(1):p.265-72.
30.Clement,S.,et al.,The lipid phosphatase SHIP2 controls insulin sensitivity.Nature,2001.409(6816):p.92-7.
31.Liu,Q.,et al.,The SH2-containing inositol polyphosphate 5-phosphatase,ship,is expressed during hematopoiesis and spermatogenesis.Blood,1998.91(8):p.2753-9.
32.Hori,H.,et al.,Association of SH2-containing inositol phosphatase 2 with the insulin resistance of diabetic db/db mice.Diabetes,2002.51(8):p.2387-94.
33.Solit,D.B.,et al.,Inhibiton of heat shock protein 90 function down-regulates Akt kinase and sensitizes tumors to Taxol.Cancer res,2003.63(9):P.2139-44
34.Scharenberg,A.M.,et al.,Phosphatidylinositol-3,4,5-trisphosphate(PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway:a target for SHIP-mediated inhibitory signals.Embo J,1998.17(7):p.1961-72.
35.Alessi,D.R.,et al.,Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha.Curr Biol,1997.7(4):p.261-9.
36.Stokoe,D.,et al.,Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B.Science,1997.277(5325):p.567-70.
37.Berridge,M.J.,Inositol trisphosphate and calcium signalling.Nature,1993.361(6410):p.315-25.
38.Luckhoff,A.and D.E.Clapham,Inositol 1,3,4,5-tetrakisphosphate activates an endothelial Ca(2+)-permeable channel Nature,1992.355(6358):p.356-8.
39.O'Rourke,F.,E.Matthews,and M.B.Feinstein,Isolation of InsP4 and InsP6 binding proteins from human platelets:InsP4 promotes Ca2+effiux from inside-out plasma membrane vesicles containing 104 kDa GAPlIP4BPprotein.Biochem J,1996.315(Pt 3):p.1027-34.
40.Fukuda,M.,et al.,Mutation of the pleckstrin homology domain of Bruton's tyrosine kinase in immunodeficiency impaired inositol 1,3,4,5-tetrakisphosphate binding capacity.J Biol Chem,1996.271(48):p.30303-6.
41.Tridandapani,S.,et al.,Negative signaling in B cells:SHIP Grbs Shc.Immunol Today,1997.18(9):p.424-7.
42.Tridandapani,S.,et al.,Negative signaling in B cells causes reduced Ras activity by reducing Shc-Grb2 interactions.J Immunol,1997.158(3):p.1125-32.
43.Liu,L.,et al.,SHIP,a new player in cytokine-induced signalling.Leukemia,1997.11(2):p.181-4.
44.Boer,A.K.,A.L.Drayer,and E.Vellenga,Effects ofoverexpression of the SH2-containing inositol phosphatase SHIP on proliferation and apoptosis of erythroid AS-E2 cells.Leukemia,2001.15(11):p.1750-7.
45.Phee,H.,A.Jacob,and K.M.Coggeshall,Enzymatic activity of the Src homology 2domain-containing inositol phosphatase is regulated by a plasma membrane location.J Biol Chem,2000.275(25):p.19090-7.
46.Luo,J.M.,et al.,Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemia.Leukemia,2003.17(1):p.1-8.
47.Mancini,A.,et al.,The SH2-containing inositol 5-phosphatase(SHIP)-1 is implicated in the control of cell-cell junction and induces dissociation and dispersion of MDCK cells.Oncogene,2002.21(10):p.1477-84.
48.Helgason,C.D.,et al.,Targeted disruption of SHIP leads to hemopoietic perturbations,lung pathology,and a shortened life span.Genes Dev,1998.12(11):p.1610-20.
49.Daley,G.Q.,R.A.Van Etten,and D.Baltimore,Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome.Science,1990.247(4944):p.824-30.
50.Elefanty,A.G.,I.K.Hariharan,and S.Cory,bcr-abl,the hallmark of chronic myeloid leukaemia in man,induces multiple haemopoietic neoplasms in mice.Embo J,1990.9(4):p.1069-78.
51.Heisterkamp,N.,et al.,Acute leukaemia in bcr/abl transgenic mice.Nature,1990.344(6263):p.251-3.
52 Malbec,O.,et al,.Src homology 2 domain-containing inositol 5-phosphatase I mediates cell cycle arrest by FcgammaRIIB.J Biol Chem,2001.276(32):P.30381-91
53.Ono,M.,et al.,Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling.Cell,1997.90(2):p.293-301.
54.Ashman,R.F.,D.Peckham,and L.L.Stunz,Fc receptor off-signal in the B cell involves apoptosis.J Immunol,1996.157(1):p.5-11.
55.Marte,B.M.and J.Downward,PKB/Akt:connecting phosphoinositide 3-kinase to cell survival and beyond.Trends Biochem Sci,1997.22(9):p.355-8.
56.Helgason,C.D.,et al.,A dual role for Src homology 2 domain-containing inositol-5-phosphatase(SHIP)in immunity:aberrant development and enhanced function of b lymphocytes in ship-/-mice.J Exp Med,2000.191(5):p.781-94.
57.Oki,S.,et al.,Dokl and SHIP act as negative regulators of v-Abl-induced pre-B cell transformation,proliferation and Ras/Erk activation.Cell Cycle,2005.4(2):p.310-4.
58.Liu,L.,et al.,The Src homology 2(SH2)domain of SH2-containing inositol phosphatase (SHIP)is essential for tyrosine phosphorylation of SHIP,its association with Shc,and its induction ofapoptosis.J Biol Chem,1997.272(14):p.8983-8.
59.Aman,M.J.,et al.,The inositol phosphatase SHIP inhibits Akt/PKB activation in B cells.J Biol Chem,1998.273(51):p.33922-8.
60.Phee,H.,A.Jacob,and K.M.Coggeshall,Enzymatic activity of the Src homology 2domain-containing inositol phosphatase is regulated by a plasma membrane location.J Biol Chem,2000.275(25):p.19090-7.
61.Sattler,M.and R.Salgia,Activation of hematopoietic growth factor signal transduction pathways by the human oncogene BCR/ABL.Cytokine Growth Factor Rev,1997.8(1):p.63-79.
62.Verfaillie,C.M.,J.B.McCarthy,and P.B.McGlave,Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia.Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV.J Clin Invest,1992.90(4):p.1232-41.
63.Salgia,R.,et al.,BCR/ABL induces multiple abnormalities of cytoskeletal function.J Clin Invest,1997.100(1):p.46-57.
64.Noguchi,T.,et al.,Tyrosine phosphorylation of p62(Dok)induced by cell adhesion and insulin:possible role in cell migration.Embo J,1999.18(7):p.1748-60.
65.Stetler-Stevenson,W.G.,Matrix metalloproteinases in angiogenesis:a moving target for therapeutic intervention.J Clin Invest,1999.103(9):p.1237-41.
66.Xing,W.and M.Hamaguchi,Effects of SHIP-1 on MMP2 secretion and invasion of SR3Y1cells.J Genet Genomics,2007.34(4):p.285-93.
67.Luo,J.M.,et al.,Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemia.Leukemia,2003.17(1):p.1-8.
68.许家仁、 李建勇等,急性髄性白血病SHIP基因突变和SNP的研究,江苏医药2006年12月第32卷第12期1103-1104页。
69.Giuriato,S.,et al.,Tyrosine phosphorylation and relocation of SHIP are integrin-mediated in thrombin-stimulated human bloodplatelets.J Biol Chem,1997.272(43):p.26857-63.
70.Backers,K.,et al.,The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases.Adv Enzyme Regul,2003.43:p.15-28.
71.Giuriato,S.,et al.,SH2-containing inositol 5-phosphatases 1 and 2 in blood platelets:their interactions and roles in the control of phosphatidylinositol 3,4,5-trisphosphate levels.Biochem J,2003.376(Pt 1):p.199-207.
72.Beutler,B.and E.T.Rietschel,Innate immune sensing and its roots:the story of endotoxin.Nat Rev Immunol,2003.3(2):p.169-76.
73.Valderrama-Carvajal,H.,et al.,Activin/TGF-beta induce apoptosis through Smad-dependent expression of the lipidphosphatase SHIP.Nat Cell Biol,2002.4(12):p.963-9.
74.Sly,L.M.,et al.,LPS-induced upregulation of SHIP is essential for endotoxin tolerance.Immunity,2004.21(2):p.227-39.
75.Parsa,K.V.,et al.,Macrophage pro-inflammatory response to Francisella novicida infection is regulated by SHIP.PLoS Pathog,2006.2(7):p.e71.
76.Harder,K.W.,et al.,Perturbed myelo/erythropoiesis in Lyn-deficient mice is similar to that in mice lacking the inhibitory phosphatases SHP-1 and SHIP-1.Blood,2004.104(13):p.3901-10.
77.Desponts,C.,et al.,SHIP deficiency enhances HSC proliferation and survival but compromises homing and repopulation.Blood,2006.107(11):p.4338-45.
78.Coffer,P.J.and J.R.Woodgett,Molecular cloning and characterisation of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C families.Eur J Biochem,1991.201(2):p.475-81.
79.Hidalgo,M.and E.K.Rowinsky,The rapamycin-sensitive signal transduction pathway as a target for cancer therapy.Oncogene,2000.19(56):p.6680-6686
80.Osaki,M.,M.Oshimura,and H.Ito,PI3K-Akt pathway:its functions and alterations in human cancer.Apoptosis,2004.9(6):p.667-76.
81.Kim,S.H.,et al.,Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor,MEK/ERK1,2 andPI3K/Akt.Cell Mol Life Sci,2006.63(7-8):p.930-8.
82.Levine,D.A.,et al.,Frequent mutation of the PIK3CA gene in ovarian and breast cancers.Clin Cancer Res,2005.11(8):p.2875-8.
83.Knobbe,C.B.,A.Trampe-Kieslich,and G.Reifenberger,Genetic alteration and expression of the phosphoinositol-3-kinase/Akt pathway genes PIK3CA and PIKE in human glioblastomas.Neuropathol Appl Neurobiol,2005.31(5):p.486-90.
84.Oda,K.,et al.,High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial careinoma.Cancer Res,2005.65(23):p.10669-73.
85.Or,Y.Y.,et al.,Characterization of chromosome 3q and 12q amplicons in nasopharyngeal carcinoma cell lines.Int J Oncol,2005.26(1):p.49-56.
86.Wang,J.,et al.,Colon carcinoma cells harboring PIK3CA mutations display resistance to growth factor deprivation induced apoptosis.Mol Cancer Ther,2007.6(3):p.1143-50.
87.Nyakern,M.,et al.,Frequent elevation of Akt kinase phosphorylation in blood marrow and peripheral blood mononuclear cells from high-risk myelodysplastic syndrome patients.Leukemia,2006.20(2):p.230-8.
88.Hartmann,W.,et al.,Phosphatidylinositol 3 '-kinase/AKT signaling is activated in medulloblastoma cell proliferation and is associated with reduced expression of PTEN.Clinical Cancer Research,2006.12(10):p.3019-3027.
89.Samuels,Y.,et al.,High frequency of mutations of the PIK3CA gene in human cancers.Science,2004.304(5670):p.554.
90.Hunter,M.G.and B.R.Avalos,Phosphatidylinositol 3'-kinase andSH2-containing inositol phosphatase(SHIP)are recruited by distinct positive and negative growth-regulatory domains in the granulocyte colony-stimulating factor receptor.J Immunol,1998.160(10):p.4979-87.
91.Kim,C.H.,et al.,Altered responsiveness to chemokines due to targeted disruption of SHIP.Journal of Clinical Investigation,1999.104(12):p.1751-1759.
92.Liu,Q.,et al.,SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival.Genes Dev,1999.13(7):p.786-91.
93.Zhang,X.and P.W.Majerus,Phosphatidylinositol signalling reactions.Semin Cell Dev Biol,1998.9(2):p.153-60.
94.Kelliher,M.A.,et al.,Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.Proc Natl Acad Sci U S A,1990.87(17):p.6649-53.
95.Rychahou,P.G.,et al.,Targeted molecular therapy of the PI3K pathway:therapeutic significance of PI3K subunit targeting in colorectal carcinoma.Ann Surg,2006.243(6):p.833-42;discussion 843-4.
96.Downes,C.P.,et al.,Antagonism of PI 3-kinase-dependent signalling pathways by the tumnout suppressor protein,PTEN.Biochem Soc Trans,2001.29(Pt 6):p.846-51.
97 Kim TJ,et al.Increased expression of pAKT is associated with radiation resistance in cervical cancer[J].Korean J Gynecol Oncol,2006,17(1):33-38.
98 Henshall,D.C.,et al.,Activation of Bcl-2-associated death protein and counter-response of Akt within cell populations during seizure-induced neuronal death.J Neurosci,2002.22(19):P.8458-65.
99 Xin,M.and X.Deng,Nicotine inactivating of the proapoptotic function of Bax through phosphorylation.J Biol Chem,2005.280(11):P.10781-9.
100 Bartling,B.,et al.,Shear stress-dependent expression of apoptosis-regulating genes in endothelial cells.Biochem Biophys Res Commun,2000.278(3):P.740-6
101 LI N,BANIN S,OUYANG H,et al.A TM is required for lkappa B kinase(IKKk)activation in response to DNA double strand breaks[J].J Biol Chem,2001,276(12):8898-8903
102 Gibson,E.M.,et al.,Epidermal growth factor protects epithelial-derived cells from tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by inhibiting cytochrome c release.Cancer Res,2002.62(2):P.488-96
103 Coffey,J.C.,et al.,Phosphoinositide 3-kinase accelerates postoperative tumor growth by inhibiting apoptosis and enhancing resistance to chemotherapy-induced apoptosis.Novel role for an old enermy.J Biol Chem,2005.280(22):P.20968-77
2.Tu,Z.,et al.,Embryonic and hematopoietic stem cells express a novel SH2-containing inositol 5'-phosphatase isoform that partners with the Grb2 adapter protein.Blood,2001.98(7):p.2028-38.
3.Backers,K.,et al.,The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases.Adv Enzyme Regul,2003.43:p.15-28.
4.Ware,M.D.,et al.,Cloning and characterization of human SHIP,the 145-kD inositol 5-phosphatase that associates with SHC after cytokine stimulation.Blood,1996.88(8):p.2833-40.
5.Sly,L.M.,et al.,SHIP,SHIP2,and PTEN activities are regulated in vivo by modulation of their protein levels:SHIP is up-regulated in macrophages and mast cells by lipopolysaccharide.Exp Hematol,2003.31(12):p.1170-81.
6.Velazquez,L.,et al.,The shc adaptor protein forms interdependent phosphotyrosine-mediated protein complexes in mast cells stimulated with interleukin 3.Blood,2000.96(1):p.132-8.
7.Bone,H.and M.J.Welham,Shc associates with the IL-3 receptor beta subunit,SHIP and Gab2 following IL-3 stimulation.Contribution of Shc PTB and SH2 domains.Cell Signal,2000.12(3):p.183-94.
8.Lee,J.O.,et al.,Crystal structure of the PTEN tumor suppressor:implications for its phosphoinositide phosphatase activity and membrane association.Cell,1999.99(3):p.323-34.
9.Giri,D.and M.Ittmann,Inactivation of the PTEN tumor suppressor gene is associated with increased angiogenesis in clinically localized prostate carcinoma.Hum Pathol,1999.30(4):p.419-24.
10.Damen,J.E.,et al.,The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase.Proc Natl Acad Sci USA,1996.93(4):p.1689-93.
11.Rauh,M.J.,et al.,Role of Src homology 2-containing-inositol 5'-phosphatase(SHIP) in mast cells and macrophages.Biochem Soc Trans,2003.31(Pt 1):p.286-91.
12.Liu,Q.,et al.,The SH2-containing inositol polyphosphate 5-phosphatase,ship,is expressed during hematopoiesis and spermatogenesis.Blood,1998.91(8):p.2753-9.
13.Brauweiler,A.,et al.,Partially distinct molecular mechanisms mediate inhibitory FcgammaRIIB signaling in resting and activated B cells.J Immunol,2001.167(1):p.204-11.
14.Maresco,D.L.,et al.,The SH2-containing 5'-inositol phosphatase(SHIP) is tyrosine phosphorylated after Fc gamma receptor clustering in monocytes.J Immunol,1999.162(11):p.6458-65.
15.Cox,D.,et al.,A regulatory role for Src homology 2 domain-containing inositol 5'-phosphatase(SHIP) in phagocytosis mediated by Fc gamma receptors and complement receptor 3(alpha(M)beta(2);CD11b/CD18).J Exp Med,2001.193(1):p.61-71.
16.Giuriato,S.,et al.,Tyrosine phosphorylation and relocation of SHIP are integrin-mediated in thrombin-stimulated human blood platelets.J Biol Chem,1997.272(43):p.26857-63.
17.Maxwell,M.J.,et al.,SHIP1 and Lyn Kinase Negatively Regulate Integrin alpha Ⅱb beta 3 signaling in platelets.J Biol Chem,2004.279(31):p.32196-204.
18.Lucas,D.M.and L.R.Rohrschneider,A novel spliced form of SH2-containing inositol phosphatase is expressed during myeloid development.Blood,1999.93(6):p.1922-33.
19.Wolf,I.,et al.,Cloning of the genomic locus of mouse SH2 containing inositol 5-phosphatase (SHIP) and a novel 110-kDa splice isoform,SHIPdelta.Genomics,2000.69(1):p.104-12.
20.Tu,Z.,et al.,Embryonic and hematopoietic stem cells express a novel SH2-containing inositol 5'-phosphatase isoform that partners with the Grb2 adapter protein.Blood,2001.98(7):p.2028-38.
21.Kalesnikoff,J.,et al.,The role of SHIP in cytokine-induced signaling.Rev Physiol Biochem Pharmacol,2003.149:p.87-103.
22.Pesesse,X.,et al.,Identification of a second SH2-domain-containing protein closely related to the phosphatidylinositol polyphosphate 5-phosphatase SHIP.Biochem Biophys Res Commun,1997.239(3):p.697-700.
23.Muraille,E.,et al.,Distribution of the src-homology-2-domain-containing inositol 5-phosphatase SHIP-2 in both non-haemopoietic and haemopoietic cells and possible involvement of SHIP-2 in negative signalling of B-cells.Biochem J,1999.342 Pt 3:p.697-705.
24.Wisniewski,D.,et al.,A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase(SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene(SHC) in chronic myelogenous leukemia progenitor cells.Blood,1999.93(8):p.2707-20.
25.Bruyns,C.,et al.,The two SH2-domain-containing inositol 5-phosphatases SHIP1 and SHIP2are coexpressed in human T lymphocytes.Biol Chem,1999.380(7-8):p.969-74.
26.Pesesse,X.,et al.,The SH2 domain containing inositol 5-phosphatase SHIP2 displays phosphatidylinositol 3,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate 5-phosphatase activity.FEBS Lett,1998.437(3):p.301-3.
27.Dyson,J.M.,et al.,The SH2-containing inositol polyphosphate 5-phosphatase,SHIP-2,binds filamin and regulates submembraneous actin.J Cell Biol,2001.155(6):p.1065-79.
28.Krystal,G.,Lipid phosphatases in the immune system.Semin Immunol,2000.12(4):p.397-403.
29.Ishihara,H.,et al.,Molecular cloning of rat SH2-containing inositol phosphatase 2(SHIP2)and its role in the regulation of insulin signaling.Biochem Biophys Res Commun,1999.260(1):p.265-72.
30.Clement,S.,et al.,The lipid phosphatase SHIP2 controls insulin sensitivity.Nature,2001.409(6816):p.92-7.
31.Liu,Q.,et al.,The SH2-containing inositol polyphosphate 5-phosphatase,ship,is expressed during hematopoiesis and spermatogenesis.Blood,1998.91(8):p.2753-9.
32.Hori,H.,et al.,Association of SH2-containing inositol phosphatase 2 with the insulin resistance of diabetic db/db mice.Diabetes,2002.51(8):p.2387-94.
33.Solit,D.B.,et al.,Inhibiton of heat shock protein 90 function down-regulates Akt kinase and sensitizes tumors to Taxol.Cancer res,2003.63(9):P.2139-44
34.Scharenberg,A.M.,et al.,Phosphatidylinositol-3,4,5-trisphosphate(PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway:a target for SHIP-mediated inhibitory signals.Embo J,1998.17(7):p.1961-72.
35.Alessi,D.R.,et al.,Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha.Curr Biol,1997.7(4):p.261-9.
36.Stokoe,D.,et al.,Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B.Science,1997.277(5325):p.567-70.
37.Berridge,M.J.,Inositol trisphosphate and calcium signalling.Nature,1993.361(6410):p.315-25.
38.Luckhoff,A.and D.E.Clapham,Inositol 1,3,4,5-tetrakisphosphate activates an endothelial Ca(2+)-permeable channel Nature,1992.355(6358):p.356-8.
39.O'Rourke,F.,E.Matthews,and M.B.Feinstein,Isolation of InsP4 and InsP6 binding proteins from human platelets:InsP4 promotes Ca2+effiux from inside-out plasma membrane vesicles containing 104 kDa GAPlIP4BPprotein.Biochem J,1996.315(Pt 3):p.1027-34.
40.Fukuda,M.,et al.,Mutation of the pleckstrin homology domain of Bruton's tyrosine kinase in immunodeficiency impaired inositol 1,3,4,5-tetrakisphosphate binding capacity.J Biol Chem,1996.271(48):p.30303-6.
41.Tridandapani,S.,et al.,Negative signaling in B cells:SHIP Grbs Shc.Immunol Today,1997.18(9):p.424-7.
42.Tridandapani,S.,et al.,Negative signaling in B cells causes reduced Ras activity by reducing Shc-Grb2 interactions.J Immunol,1997.158(3):p.1125-32.
43.Liu,L.,et al.,SHIP,a new player in cytokine-induced signalling.Leukemia,1997.11(2):p.181-4.
44.Boer,A.K.,A.L.Drayer,and E.Vellenga,Effects ofoverexpression of the SH2-containing inositol phosphatase SHIP on proliferation and apoptosis of erythroid AS-E2 cells.Leukemia,2001.15(11):p.1750-7.
45.Phee,H.,A.Jacob,and K.M.Coggeshall,Enzymatic activity of the Src homology 2domain-containing inositol phosphatase is regulated by a plasma membrane location.J Biol Chem,2000.275(25):p.19090-7.
46.Luo,J.M.,et al.,Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemia.Leukemia,2003.17(1):p.1-8.
47.Mancini,A.,et al.,The SH2-containing inositol 5-phosphatase(SHIP)-1 is implicated in the control of cell-cell junction and induces dissociation and dispersion of MDCK cells.Oncogene,2002.21(10):p.1477-84.
48.Helgason,C.D.,et al.,Targeted disruption of SHIP leads to hemopoietic perturbations,lung pathology,and a shortened life span.Genes Dev,1998.12(11):p.1610-20.
49.Daley,G.Q.,R.A.Van Etten,and D.Baltimore,Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome.Science,1990.247(4944):p.824-30.
50.Elefanty,A.G.,I.K.Hariharan,and S.Cory,bcr-abl,the hallmark of chronic myeloid leukaemia in man,induces multiple haemopoietic neoplasms in mice.Embo J,1990.9(4):p.1069-78.
51.Heisterkamp,N.,et al.,Acute leukaemia in bcr/abl transgenic mice.Nature,1990.344(6263):p.251-3.
52 Malbec,O.,et al,.Src homology 2 domain-containing inositol 5-phosphatase I mediates cell cycle arrest by FcgammaRIIB.J Biol Chem,2001.276(32):P.30381-91
53.Ono,M.,et al.,Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling.Cell,1997.90(2):p.293-301.
54.Ashman,R.F.,D.Peckham,and L.L.Stunz,Fc receptor off-signal in the B cell involves apoptosis.J Immunol,1996.157(1):p.5-11.
55.Marte,B.M.and J.Downward,PKB/Akt:connecting phosphoinositide 3-kinase to cell survival and beyond.Trends Biochem Sci,1997.22(9):p.355-8.
56.Helgason,C.D.,et al.,A dual role for Src homology 2 domain-containing inositol-5-phosphatase(SHIP)in immunity:aberrant development and enhanced function of b lymphocytes in ship-/-mice.J Exp Med,2000.191(5):p.781-94.
57.Oki,S.,et al.,Dokl and SHIP act as negative regulators of v-Abl-induced pre-B cell transformation,proliferation and Ras/Erk activation.Cell Cycle,2005.4(2):p.310-4.
58.Liu,L.,et al.,The Src homology 2(SH2)domain of SH2-containing inositol phosphatase (SHIP)is essential for tyrosine phosphorylation of SHIP,its association with Shc,and its induction ofapoptosis.J Biol Chem,1997.272(14):p.8983-8.
59.Aman,M.J.,et al.,The inositol phosphatase SHIP inhibits Akt/PKB activation in B cells.J Biol Chem,1998.273(51):p.33922-8.
60.Phee,H.,A.Jacob,and K.M.Coggeshall,Enzymatic activity of the Src homology 2domain-containing inositol phosphatase is regulated by a plasma membrane location.J Biol Chem,2000.275(25):p.19090-7.
61.Sattler,M.and R.Salgia,Activation of hematopoietic growth factor signal transduction pathways by the human oncogene BCR/ABL.Cytokine Growth Factor Rev,1997.8(1):p.63-79.
62.Verfaillie,C.M.,J.B.McCarthy,and P.B.McGlave,Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia.Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV.J Clin Invest,1992.90(4):p.1232-41.
63.Salgia,R.,et al.,BCR/ABL induces multiple abnormalities of cytoskeletal function.J Clin Invest,1997.100(1):p.46-57.
64.Noguchi,T.,et al.,Tyrosine phosphorylation of p62(Dok)induced by cell adhesion and insulin:possible role in cell migration.Embo J,1999.18(7):p.1748-60.
65.Stetler-Stevenson,W.G.,Matrix metalloproteinases in angiogenesis:a moving target for therapeutic intervention.J Clin Invest,1999.103(9):p.1237-41.
66.Xing,W.and M.Hamaguchi,Effects of SHIP-1 on MMP2 secretion and invasion of SR3Y1cells.J Genet Genomics,2007.34(4):p.285-93.
67.Luo,J.M.,et al.,Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemia.Leukemia,2003.17(1):p.1-8.
68.许家仁、 李建勇等,急性髄性白血病SHIP基因突变和SNP的研究,江苏医药2006年12月第32卷第12期1103-1104页。
69.Giuriato,S.,et al.,Tyrosine phosphorylation and relocation of SHIP are integrin-mediated in thrombin-stimulated human bloodplatelets.J Biol Chem,1997.272(43):p.26857-63.
70.Backers,K.,et al.,The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases.Adv Enzyme Regul,2003.43:p.15-28.
71.Giuriato,S.,et al.,SH2-containing inositol 5-phosphatases 1 and 2 in blood platelets:their interactions and roles in the control of phosphatidylinositol 3,4,5-trisphosphate levels.Biochem J,2003.376(Pt 1):p.199-207.
72.Beutler,B.and E.T.Rietschel,Innate immune sensing and its roots:the story of endotoxin.Nat Rev Immunol,2003.3(2):p.169-76.
73.Valderrama-Carvajal,H.,et al.,Activin/TGF-beta induce apoptosis through Smad-dependent expression of the lipidphosphatase SHIP.Nat Cell Biol,2002.4(12):p.963-9.
74.Sly,L.M.,et al.,LPS-induced upregulation of SHIP is essential for endotoxin tolerance.Immunity,2004.21(2):p.227-39.
75.Parsa,K.V.,et al.,Macrophage pro-inflammatory response to Francisella novicida infection is regulated by SHIP.PLoS Pathog,2006.2(7):p.e71.
76.Harder,K.W.,et al.,Perturbed myelo/erythropoiesis in Lyn-deficient mice is similar to that in mice lacking the inhibitory phosphatases SHP-1 and SHIP-1.Blood,2004.104(13):p.3901-10.
77.Desponts,C.,et al.,SHIP deficiency enhances HSC proliferation and survival but compromises homing and repopulation.Blood,2006.107(11):p.4338-45.
78.Coffer,P.J.and J.R.Woodgett,Molecular cloning and characterisation of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C families.Eur J Biochem,1991.201(2):p.475-81.
79.Hidalgo,M.and E.K.Rowinsky,The rapamycin-sensitive signal transduction pathway as a target for cancer therapy.Oncogene,2000.19(56):p.6680-6686
80.Osaki,M.,M.Oshimura,and H.Ito,PI3K-Akt pathway:its functions and alterations in human cancer.Apoptosis,2004.9(6):p.667-76.
81.Kim,S.H.,et al.,Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor,MEK/ERK1,2 andPI3K/Akt.Cell Mol Life Sci,2006.63(7-8):p.930-8.
82.Levine,D.A.,et al.,Frequent mutation of the PIK3CA gene in ovarian and breast cancers.Clin Cancer Res,2005.11(8):p.2875-8.
83.Knobbe,C.B.,A.Trampe-Kieslich,and G.Reifenberger,Genetic alteration and expression of the phosphoinositol-3-kinase/Akt pathway genes PIK3CA and PIKE in human glioblastomas.Neuropathol Appl Neurobiol,2005.31(5):p.486-90.
84.Oda,K.,et al.,High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial careinoma.Cancer Res,2005.65(23):p.10669-73.
85.Or,Y.Y.,et al.,Characterization of chromosome 3q and 12q amplicons in nasopharyngeal carcinoma cell lines.Int J Oncol,2005.26(1):p.49-56.
86.Wang,J.,et al.,Colon carcinoma cells harboring PIK3CA mutations display resistance to growth factor deprivation induced apoptosis.Mol Cancer Ther,2007.6(3):p.1143-50.
87.Nyakern,M.,et al.,Frequent elevation of Akt kinase phosphorylation in blood marrow and peripheral blood mononuclear cells from high-risk myelodysplastic syndrome patients.Leukemia,2006.20(2):p.230-8.
88.Hartmann,W.,et al.,Phosphatidylinositol 3 '-kinase/AKT signaling is activated in medulloblastoma cell proliferation and is associated with reduced expression of PTEN.Clinical Cancer Research,2006.12(10):p.3019-3027.
89.Samuels,Y.,et al.,High frequency of mutations of the PIK3CA gene in human cancers.Science,2004.304(5670):p.554.
90.Hunter,M.G.and B.R.Avalos,Phosphatidylinositol 3'-kinase andSH2-containing inositol phosphatase(SHIP)are recruited by distinct positive and negative growth-regulatory domains in the granulocyte colony-stimulating factor receptor.J Immunol,1998.160(10):p.4979-87.
91.Kim,C.H.,et al.,Altered responsiveness to chemokines due to targeted disruption of SHIP.Journal of Clinical Investigation,1999.104(12):p.1751-1759.
92.Liu,Q.,et al.,SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival.Genes Dev,1999.13(7):p.786-91.
93.Zhang,X.and P.W.Majerus,Phosphatidylinositol signalling reactions.Semin Cell Dev Biol,1998.9(2):p.153-60.
94.Kelliher,M.A.,et al.,Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.Proc Natl Acad Sci U S A,1990.87(17):p.6649-53.
95.Rychahou,P.G.,et al.,Targeted molecular therapy of the PI3K pathway:therapeutic significance of PI3K subunit targeting in colorectal carcinoma.Ann Surg,2006.243(6):p.833-42;discussion 843-4.
96.Downes,C.P.,et al.,Antagonism of PI 3-kinase-dependent signalling pathways by the tumnout suppressor protein,PTEN.Biochem Soc Trans,2001.29(Pt 6):p.846-51.
97 Kim TJ,et al.Increased expression of pAKT is associated with radiation resistance in cervical cancer[J].Korean J Gynecol Oncol,2006,17(1):33-38.
98 Henshall,D.C.,et al.,Activation of Bcl-2-associated death protein and counter-response of Akt within cell populations during seizure-induced neuronal death.J Neurosci,2002.22(19):P.8458-65.
99 Xin,M.and X.Deng,Nicotine inactivating of the proapoptotic function of Bax through phosphorylation.J Biol Chem,2005.280(11):P.10781-9.
100 Bartling,B.,et al.,Shear stress-dependent expression of apoptosis-regulating genes in endothelial cells.Biochem Biophys Res Commun,2000.278(3):P.740-6
101 LI N,BANIN S,OUYANG H,et al.A TM is required for lkappa B kinase(IKKk)activation in response to DNA double strand breaks[J].J Biol Chem,2001,276(12):8898-8903
102 Gibson,E.M.,et al.,Epidermal growth factor protects epithelial-derived cells from tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by inhibiting cytochrome c release.Cancer Res,2002.62(2):P.488-96
103 Coffey,J.C.,et al.,Phosphoinositide 3-kinase accelerates postoperative tumor growth by inhibiting apoptosis and enhancing resistance to chemotherapy-induced apoptosis.Novel role for an old enermy.J Biol Chem,2005.280(22):P.20968-77